Table 7:
Manufacturing processes for flexible leaflet polymeric heart valves.
| Year | Author(s) | Material and process | Results | References |
|---|---|---|---|---|
| Dip molding, dip coating, dip casting | ||||
| 1959 | Kolff et al., Cleveland | PU dissolved in tetrahydrofuran (THF) and poured into an open mold | In vivo – dog implant (mitral, aortic and tricuspid), high mortality due to clotting on surface | [241] |
| 1959 | Braunwald & Morrow, Boston | Dacron fabric placed between two-piece male/female mold and filled with liquid PU | In vivo – human implant (mitral), 60 hours and 4 months | [196], [237] |
| 1977 | Reul & Ghista, HIA | Leaflet molds dipped into Avcothane-51 PU solution | In vitro – 350+ million cycles in vitro (aortic) | [163] |
| 1980 | Russell et al., Boston | Valved conduit – conduit formed first by dipping in Avcothane-51 solution, then leaflet mold inserted into conduit and filled with solution |
In vitro – 58+ million cycles In vivo – calf implant 135 days (aortic) |
[231] |
| 1982 | Wisman et al., Penn State | PU dissolved in N-N-dimethyl acetamide (DMAc), leaflet mold dipped in solution | In vivo – calf, sheep and goat implant (mitral and tricuspid), survival up to 960 days | [204] |
| 1987 | Herold et al., HIA | PU dissolved in THF or DMAc, leaflet molds made by electro-erosion and dipped in PU solution |
In vitro – 93 million cycles In vivo – calf implant up to 267 days (trileaflet prosthetic in mitral position) |
[214] |
| 1991 | Jansen et al., HIA | Leaflet molds and valve stent dipped together into PU solution, after dipping the mold is tumbled in space for even thickness distribution |
In vitro – 648 million cycles In vivo – 5 of 7 calves >150 days, outperformed bioprosthetic (trileaflet prosthetic in mitral position) |
[212], [242] |
| 1994 | Leat & Fisher, Leeds | PU dissolved in dimethyl formamide (DMF), leaflet mold dipped in solution | In vitro – 160+ million cycles | [211] |
| 1995 | Wheatley et al., Glasgow | Leaflet molds made by electrical discharge machining (EDM) and dipped in Elast-Eon™ PU-silicone copolymer solution |
In vitro – 800 million cycles In vivo – 6-month survival in sheep (trileaflet prosthetic in mitral position) |
[35]–[38], [173] [240], [243], [244] |
| 2001 | Fisher et al., Leeds | Leaflet mold dipped in Tecothane™ 80A PU solution | In vitro – 362 million cycles (trileaflet) | [39], [245] |
| 2003 | Daebritz et al., Munich | Droplets of dissolved ADIAMat PCU deposited onto leaflet mold, thickness intentionally varied to reduce stress at commissures |
In vitro – 600/1000 million cycles (aortic/mitral) In vivo – good survival to 5 months in calves, outperformed bioprosthetic |
[42], [43], [197] [213] |
| 2005 | Yoganathan et al., Georgia Tech | Leaflet mold dipped in Elast-Eon™ solution | In vitro – low flow regions corresponding with thrombus formation in vivo. Thicker leaflets correspond to greater leakage. | [246], [247] |
| 2006 | Metzner et al., Kiel & Aachen | Dip-coating in PU to form valved stent for percutaneous, catheter-based delivery | In vivo – good survival in sheep (8 of 9, pulmonary) to 4 weeks | [248], [249] |
| 2009 | Seifalian et al., UCL | POSS-PCU dissolved in DMAc, leaflet molds dipped in solution, design later adapted for percutaneous delivery, dipping process automated to improve reproducibility |
In vitro – lower leakage vs. commercial TAVI bioprosthetics |
[46], [ 188] [47], [185] |
| 2016 | Zilla et al., SAT | Dip molding or spray molding of dissolved SAT polymer onto leaflet mold |
In vitro – 600 million cycles In vivo – 8 weeks in sheep |
[250], [251] |
| Injection/compression/cavity molding | ||||
| 1958, 1966 | Roe et al., San Francisco | Silastic silicone, heated to 177 °C in a compression molding die for 1 hour, removed from die and heat cured at 204 °C for 4 hours In a later iteration, SE-555 silicone heated to 132 °F in the molding die at 100 MPa |
In vitro – 786 million In vivo – 18 clinical human implants, 4 post-operative survivors from 79-100 months (aortic) |
[200]–[202], [239] |
| 1965 | Braunwald & Morrow, Boston | Plain PTFE fabric and PTFE fabric coated with PTFE dispersion | In vivo – 23 clinical human implants, 15 died or required reoperation due to severe regurgitation (aortic) | [252] |
| 1973 | Mohri, U. of Washington | Silastic silicone injected into a compression molding die, pressurized to 41 MPa for 5 minutes, air and overflow evacuated, then pressure increased to 62 MPa for 1 minute, vulcanization in oven at 148.9 °C for 50 minutes, then valve removed from die and cured at 148.9 °C for 2.5 hours | In vitro – durability equivalent to 18-25.5 years | [253] |
| 1980 | Chetta & Lloyd, Notre Dame | Two-piece male/female mold filled with RTV-615, a room temperature vulcanizing silicone rubber | In vitro – functioned for 280 million cycles until work hardening of silicone rubber prevented leaflet opening | [222] |
| 1989 | Kolff & Yu, Utah | Silastic silicone, stent and leaflet molded at same time on a cylindrical mold | N/A | [254] |
| 2004 | Jiang et al., Ontario | Polyvinyl alcohol cryogel (PVA-C), cavity mold injected with hot PVA-water solution, then sealed, clamped and immersed in water bath with controlled freeze/thaw cycles. | N/A | [205] |
| 2009 | Mohammadi et al., Ontario | Polyvinyl alcohol-bacterial cellulose (PVA-BC) composite, cavity molding process similar to Jiang et al. | N/A | [176], [190], [191] |
| 2013 | Bluestein et al., Stony Brook | Raw xSIBS compressed under vacuum in a mold at 260 °C with 1 ton of force for 30 minutes. Mold fabricated by EDM. | In vitro – 400+ million cycles, hydrodynamics comparable to bioprostheses | [45], [165], [215] |
| 2014 | Stasiak et al., Cambridge, UK | Injection molding of SIS30 block copolymer to introduce bidirectional, anisotropic cylinder orientatio | In vitro – 3+ million cycles | [218] |
| 2015 | De Gaetano et al., Cambridge, UK | Compression molding of styrene block copolymers to introduce anisotropy and microstructural orientation | In vitro – EOA and regurgitation comparable to mechanical and bioprosthetic valves | [255], [256] |
| Film fabrication | ||||
| 1960 | McGoon, Mayo Clinic | PTFE cloth impregnated with PU | In vivo – 98 implantations | [181] |
| 1974 | Gerring et al., Oxford | Terylene (PET) fabric coated with Silastic by press curing, then cut and bonded to sewing ring Also, films of Biomer (PU) cast from solution onto glass plate, then cut and bonded to sewing ring | In vivo – survival up to 30+/21+ months for Silastic/Biomer implants in calves (pulmonary) | [182] |
| 1977 | Imamura et al., Mayo Clinic | Gore-Tex® (ePTFE) assembled in multilayer laminate to reduce porosity and improve strength, sutured to support frame with additional ePTFE layers for reinforcement | In vivo – survivability 12/28 dogs up to 15 months (tricuspid) | [216], [257] |
| 1989 | Kolff & Yu, Utah | Pellethane® polyurethane, vacuum formed or solution cast | In vivo – 5/5 sheep up to 15 months | [254] |
| 1990 | Nistal et al., Spain | Gore-Tex® ePTFE (no report of fabrication process) | In vivo – survival up to 42 weeks in sheep (tricuspid) | [224] |
| 1995 | Leat & Fisher, Leeds | Solvent casting of flat PU films, cut and bonded to valve frame, then thermally formed into alpharabola geometry on a mold | In vitro – 100 million cycles | [161], [211] |
| 2005 | Koh et al., Osaka | Gore-Tex® (ePTFE) membrane cut and sutured to either bovine pericardium or Gore-Tex® vascular grafts. Radiopaque markers sutured to center of leaflet free edges to imitate the nodulus of Arantius | In vivo – 47 human implants (pulmonary), no significant obstruction after 1 month – 7 years | [225] |
| 2009 | Ando & Takahashi, Tokyo | Gore-Tex® (ePTFE) membrane manually cut, folded, and sutured to create three pockets that comprise the valve, then sutured within a Dacron conduit to make a valved conduit | In vivo – 139 human implants (pulmonary), good survivability and competence at 10 years | [40] |
| 2010 | Wang et al., Innovia | SIBS dissolved in toluene and cast around a Dacron mesh to produce a flat sheet with uniform thickness, leaflet cut and sewn onto a molded SIBS stent using polyester sutures | In vivo – poor survivability (1/4) of sheep aortic implant, valve failure due to material damage and calcification | [165], [169], [258] |
| 2014 | Prawel et al., Colorado State | Leaflets formed with a cylindrical sheet of hyaluronanlinear low-density polyethylene interpenetrating networks (HA/LLDPE IPN) | In vitro – EOA higher than bioprostheses, comparable regurgitation | [235] |
| 2014 | Zhang et al., Shanghai | Films of Gore-Tex® (ePTFE) dip-coated in phosphorylcholine, then trimmed and sutured to stent | In vivo – good survivability in sheep (9 of 9) to 4 weeks (pulmonary) | [41] |
| 2017 | Basir et al., Netherlands | Valve made from textile of woven ultra-high-molecular-weight polyethylene (UHMWPE) fibers and affixed to stent | In vivo – 17/18 sheep survived to 6 months (pulmonary) | [259] |
| 2019 | Guo et al., Shenyang | Anisotropic PET fabric impregnated with PEGDA hydrogel, trimmed and sutured to nitinol stent | In vitro – Large EOA and low regurgitation | [236] |